Abbott EVP uses shares to cover tax liability

Abbott Laboratories executive vice president Louis H. Morrone reported a routine tax-withholding transaction in company stock.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Abbott Laboratories executive vice president Louis H. Morrone reported a routine tax-withholding transaction in company stock. On the reported date, 269 common shares were withheld at $92.71 per share to cover tax obligations, leaving him with 76,574 common shares held directly. He also has an indirect holding of 12 common shares through a profit sharing trust, reflecting the balance in the Abbott Laboratories Stock Retirement Trust as of June 30, 2026.

Insider Trade Summary

Exercise Price or Tax Liability: 269 shares

Exercise Price or Tax Liability 2 txns

Insider Morrone Louis H.

Role EXECUTIVE VICE PRESIDENT

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common shares without par value	269	$92.71	$25K
holding	Common shares without par value	--	--	--

Holdings After Transaction: Common shares without par value — 76,574 shares (Direct); Common shares without par value — 12 shares (Indirect, Profit Sharing Trust)

Footnotes (1)

F1. Balance in the Abbott Laboratories Stock Retirement Trust as of June 30, 2026.

Key Figures

Tax-withholding shares: 269 shares Withholding price: $92.71 per share Direct holdings after transaction: 76,574 shares +2 more

5 metrics

Tax-withholding shares 269 shares Shares withheld to cover tax obligations

Withholding price $92.71 per share Value used for 269-share tax-withholding disposition

Direct holdings after transaction 76,574 shares Common shares held directly following tax-withholding

Indirect trust holdings 12 shares Balance in Abbott Laboratories Stock Retirement Trust as of June 30, 2026

Tax-withholding transactions 1 transaction Count of F-code tax-withholding dispositions in this filing

Key Terms

tax-withholding disposition, Profit Sharing Trust, Abbott Laboratories Stock Retirement Trust, Common shares without par value

4 terms

tax-withholding disposition financial

"269 common shares were withheld at $92.71 per share to cover tax obligations"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Abbott Laboratories Stock Retirement Trust financial

"reflecting the balance in the Abbott Laboratories Stock Retirement Trust as of June 30, 2026"

Common shares without par value financial

"reported a routine tax-withholding transaction in company stock, described as common shares without par value"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ABBOTT LABORATORIES (ABT) report for Louis H. Morrone?

ABBOTT LABORATORIES reported that executive vice president Louis H. Morrone had 269 common shares withheld to cover tax obligations. This was a tax-withholding disposition, not an open-market sale, and it reflects routine handling of equity-based compensation.

How many ABBOTT LABORATORIES shares were withheld for taxes in this Form 4?

A total of 269 ABBOTT LABORATORIES common shares were withheld to satisfy tax liabilities at a price of $92.71 per share. This reduced the shares delivered to the executive but did not involve a market sale transaction.

How many ABBOTT LABORATORIES shares does Louis H. Morrone hold after this filing?

After the tax-withholding disposition, Louis H. Morrone directly holds 76,574 ABBOTT LABORATORIES common shares. In addition, he has an indirect position of 12 common shares held through a profit sharing trust associated with the Abbott Laboratories Stock Retirement Trust.

Was the ABBOTT LABORATORIES Form 4 filing a stock sale by Louis H. Morrone?

The Form 4 does not report an open-market stock sale. It shows 269 common shares used as a tax-withholding disposition, meaning shares were withheld to pay tax obligations rather than sold in the market for cash proceeds.

What is the nature of Louis H. Morrone’s indirect ABBOTT LABORATORIES holdings?

Louis H. Morrone’s indirect ABBOTT LABORATORIES holding consists of 12 common shares held through a profit sharing trust. A footnote describes this as the balance in the Abbott Laboratories Stock Retirement Trust as of June 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/01/2026 - 05:04 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morrone Louis H.

(Last)

(First)

(Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK

ILLINOIS

60064

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EXECUTIVE VICE PRESIDENT

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common shares without par value	06/30/2026		F		269	D	$92.71	76,574	D
Common shares without par value								12⁽¹⁾	I	Profit Sharing Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of June 30, 2026.

	/s/ Louis H. Morrone by Jessica H. Paik, Attorney-in-Fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR